BioRender 图标

Epigenomics (symbol) 1

Epigenomics (symbol) 1 - Editable icon of symbolic representation of genomics shown as a DNA strand with circular modifications on top of a circle
[{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace78/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace78/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace79/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace79/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7a/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7a/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7b/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7b/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7c/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7c/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7d/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7d/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7e/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7e/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace7f/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace7f/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace80/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace80/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace81/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace81/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace82/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace82/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace83/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace83/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace84/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace84/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace85/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace85/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace86/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace86/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace87/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace87/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace88/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace88/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace89/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace89/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8a/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8a/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8b/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8b/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8c/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8c/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8d/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8d/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8e/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8e/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace8f/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace8f/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace90/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace90/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace91/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace91/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace92/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace92/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace93/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace93/67f41c4f5789a559ab3abe7f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f43d645789a559ab3ace94/67f41c4f5789a559ab3abe7f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f43d645789a559ab3ace94/67f41c4f5789a559ab3abe7f.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
epigenomics,epigenetics,modification,regulation,histone,dna,marks,markers,remodeling,chromatin,regulation,control,differentiation,expression,hertible gene,gene,mapping,developmental epigenomics,environmental epigenomics,multiomics,multi-omics integration,omics,systems biology,integrative omics,biological networks,cross-omics analysis,precision medicine,data-driven biology,molecular profiling,personalized medicine,biological systems integration,high-throughput biology,computational omics,bioinformatics,multi-layered omics,functional omics,omics synergy,schematic,symbol,symbolic,sign,icon,iconography,mark,signify,simple,content-refinement-AI-expansion,epigenomics,multiomics
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Epigenomics (symbol) 1 icon JPEG

Epigenomics (symbol) 1 icon PNG

Epigenomics (symbol) 1 icon SVG

Epigenomics (symbol) 1 icon GIF

BioRender 图标常见问题解答

How are scientists using the Epigenomics (symbol) 1 icon in their work?

BioRender users often use the Epigenomics (symbol) 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Graphs and Symbols.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Epigenomics (symbol) 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Epigenomics (symbol) 1 icon customizable in BioRender?

Most icons in BioRender, including the Epigenomics (symbol) 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Epigenomics (symbol) 1 icon for publication or presentations?

Yes, figures containing the Epigenomics (symbol) 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Epigenomics (symbol) 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Epigenomics (symbol) 1 icon — especially those focused on Graphs and Symbols. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Epigenomics (symbol) 1 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon